Phase-specific cancer-immune model considering acquired resistance to therapeutic agents

DOI10.1016/j.amc.2020.125555zbMath1471.92147OpenAlexW3087668731MaRDI QIDQ2661016

Jong Hyuk Byun, Il Hyo Jung

Publication date: 1 April 2021

Published in: Applied Mathematics and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.amc.2020.125555

zbMATH Keywords

immunotherapyage-structured modelpharmacokinetics and pharmacodynamics (PKPD)cancer phase-specific modelcancer-immune modelresistance to cancer treatment

Mathematics Subject Classification ID

Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• A distribution-free approach to inducing rank correlation among input variables
• Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer
• Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics. Homogeneous and heterogeneous approaches
• Modeling immunotherapy of the tumor -- immune interaction
• Models of transcription factor binding: sensitivity of activation functions to model assumptions
• A fractional-order infectivity SIR model
• A methodology for performing global uncertainty and sensitivity analysis in systems biology
• A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy
• Mathematical modeling of the receptor-mediated endocytosis process of targeted therapeutic agents in drug delivery systems
• Generalizations of the `linear chain trick': incorporating more flexible dwell time distributions into mean field ODE models
• Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective
• Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
• A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
• The influence of time delay in a chaotic cancer model
• Sensitivity Analysis in Practice
• A STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMOR